Stock info Perrigo | Filter  Basic-Info

Perrigo

The past year was a good year for Perrigo investors

The stock lost over the past 12 months at around 41 percent. The period between August 2011 and August 2016 was a bad period for the investors. The stock lost around 0 percent. Perrigo's revenues between 2011 and 2015 were far from constant and moved between 3,17 billion dollars and 0 million dollars. Perrigo's net results between 2011 and 2015 were far from constant and moved between 392,97 million dollars and 0 million dollars.

Perrigo is mostly active in the pharmaceutical sector. The past 10 years the (international) industry gained at around 75 percent. Measured since 2011 the sector is 147 percent higher and over the past 12 months (December 2015-2016) there is a minus of 75 percent.

The American company paid out dividends in the past 5 years. Perrigo's dividend return over the period 2011 - 2015 was around 0,97 percent per year.

Perrigo' balance mostly financed with equity

At the end of 2015 the American company's balance sheet was worth 0 million dollars. The total debt was around 0 million dollars. This is percent of the total balance sheet.

At the end of 2015 the pharmaceutical company's market capitalization (the number of shares times the market price) equaled around 0 million dollars.

At this page you find all Perrigo's financial reports. More information about Perrigo can be found it's website. .